Eli Lilly And Stock Buy Hold or Sell Recommendation

LLY Stock  USD 777.96  0.22  0.03%   
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Eli Lilly And is 'Strong Buy'. Macroaxis provides Eli Lilly buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding LLY positions. The advice algorithm takes into account all of Eli Lilly's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Eli Lilly's buy or sell advice are summarized below:
Real Value
735.54
Target Price
603.57
Hype Value
779.28
Market Value
777.96
Naive Value
816.15
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Eli Lilly And given historical horizon and risk tolerance towards Eli Lilly. When Macroaxis issues a 'buy' or 'sell' recommendation for Eli Lilly And, the advice is generated through an automated system that utilizes algorithms and statistical models.
  
Check out Eli Lilly Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Eli and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Eli Lilly And. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Execute Eli Lilly Buy or Sell Advice

The Eli recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Eli Lilly And. Macroaxis does not own or have any residual interests in Eli Lilly And or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Eli Lilly's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Eli LillyBuy Eli Lilly
Strong Buy

Market Performance

SolidDetails

Volatility

Very steadyDetails

Hype Condition

Low keyDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Very LowDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Investor Sentiment

ImpartialDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

HealthyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Possible ManipulatorDetails
For the selected time horizon Eli Lilly And has a Risk Adjusted Performance of 0.1759, Jensen Alpha of 0.417, Total Risk Alpha of 0.1178, Sortino Ratio of 0.2524 and Treynor Ratio of 1.0
Macroaxis provides advice on Eli Lilly And to complement and cross-verify current analyst consensus on Eli Lilly And. Our investment recommendation engine determines the company's potential to grow exclusively from the perspective of an investor's current risk tolerance and investing horizon. To make sure Eli Lilly is not overpriced, please confirm all Eli Lilly And fundamentals, including its price to book, cash flow from operations, current liabilities, as well as the relationship between the cash and equivalents and beta . Given that Eli Lilly And has a price to book of 68.68 X, we urge you to verify Eli Lilly And market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Eli Lilly Trading Alerts and Improvement Suggestions

Over 84.0% of the company shares are owned by institutional investors
On 8th of March 2024 Eli Lilly paid $ 1.3 per share dividend to its current shareholders
Latest headline from cnbc.com: Heres a rapid-fire update on all 33 portfolio stocks including our latest buy

Eli Lilly Returns Distribution Density

The distribution of Eli Lilly's historical returns is an attempt to chart the uncertainty of Eli Lilly's future price movements. The chart of the probability distribution of Eli Lilly daily returns describes the distribution of returns around its average expected value. We use Eli Lilly And price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Eli Lilly returns is essential to provide solid investment advice for Eli Lilly.
Mean Return
0.49
Value At Risk
-1.85
Potential Upside
3.20
Standard Deviation
1.60
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Eli Lilly historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Eli Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Eli Lilly is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Eli Lilly And backward and forwards among themselves. Eli Lilly's institutional investor refers to the entity that pools money to purchase Eli Lilly's securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Geode Capital Management, Llc2023-12-31
16 M
Morgan Stanley - Brokerage Accounts2023-12-31
12.7 M
Wellington Management Company Llp2023-12-31
11.8 M
Norges Bank2023-12-31
10.3 M
Bank Of America Corp2023-12-31
9.9 M
Goldman Sachs Group Inc2023-12-31
9.4 M
Northern Trust Corp2023-12-31
9.1 M
Jennison Associates Llc2023-12-31
7.6 M
Capital Research Global Investors2023-12-31
7.6 M
Lilly Endowment Inc2023-12-31
99.8 M
Vanguard Group Inc2023-12-31
71.6 M
Note, although Eli Lilly's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Eli Lilly Cash Flow Accounts

201920202021202220232024 (projected)
Change To Inventory(258.7M)(533.4M)(235.9M)(599.7M)(1.4B)(1.4B)
Change In Cash(5.7B)1.3B161.4M(1.8B)751.6M789.2M
Free Cash Flow3.5B4.5B5.4B4.6B(3.2B)(3.0B)
Depreciation1.2B1.3B1.5B1.5B1.5B1.0B
Other Non Cash Items(3.4B)(444.2M)1.6B1.1B2.2B2.4B
Dividends Paid2.4B2.7B3.1B3.5B(4.1B)(3.9B)
Capital Expenditures1.4B2.0B1.9B2.5B7.4B7.8B
Net Income8.3B6.2B5.6B6.2B5.2B3.1B
End Period Cash Flow2.3B3.7B3.8B2.1B2.8B3.4B
Investments456.2M516.7M(166M)(244M)(7.2B)(6.8B)
Change Receivables(357M)(996.7M)(127.2M)(299.6M)(269.6M)(283.1M)
Net Borrowings4.7B291.6M501.4M(62M)(71.3M)(67.7M)
Change To Netincome653.3M(270.6M)1.2B(668.4M)(601.6M)(571.5M)

Eli Lilly Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Eli Lilly or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Eli Lilly's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Eli stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over NYSE Composite
0.42
β
Beta against NYSE Composite0.48
σ
Overall volatility
1.64
Ir
Information ratio 0.22

Eli Lilly Volatility Alert

Eli Lilly And has relatively low volatility with skewness of 0.51 and kurtosis of 1.96. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Eli Lilly's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Eli Lilly's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Eli Lilly Implied Volatility

Eli Lilly's implied volatility exposes the market's sentiment of Eli Lilly And stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Eli Lilly's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Eli Lilly stock will not fluctuate a lot when Eli Lilly's options are near their expiration.

Eli Lilly Fundamentals Vs Peers

Comparing Eli Lilly's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Eli Lilly's direct or indirect competition across all of the common fundamentals between Eli Lilly and the related equities. This way, we can detect undervalued stocks with similar characteristics as Eli Lilly or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Eli Lilly's fundamental indicators could also be used in its relative valuation, which is a method of valuing Eli Lilly by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Eli Lilly to competition
FundamentalsEli LillyPeer Average
Return On Equity0.48-0.31
Return On Asset0.12-0.14
Profit Margin0.15 %(1.27) %
Operating Margin0.34 %(5.51) %
Current Valuation762.16 B16.62 B
Shares Outstanding950.77 M571.82 M
Shares Owned By Insiders0.16 %10.09 %
Shares Owned By Institutions84.34 %39.21 %
Number Of Shares Shorted5.42 M4.71 M
Price To Earning54.92 X28.72 X
Price To Book68.68 X9.51 X
Price To Sales21.68 X11.42 X
Revenue34.12 B9.43 B
Gross Profit21.91 B27.38 B
EBITDA12.46 B3.9 B
Net Income5.24 B570.98 M
Cash And Equivalents2.07 B2.7 B
Cash Per Share2.97 X5.01 X
Total Debt25.23 B5.32 B
Debt To Equity1.58 %48.70 %
Current Ratio1.13 X2.16 X
Book Value Per Share11.98 X1.93 K
Cash Flow From Operations4.24 B971.22 M
Short Ratio1.45 X4.00 X
Earnings Per Share5.84 X3.12 X
Price To Earnings To Growth1.47 X4.89 X
Target Price809.74
Number Of Employees43 K18.84 K
Beta0.34-0.15
Market Capitalization739.87 B19.03 B
Total Asset64.01 B29.47 B
Retained Earnings10.31 B9.33 B
Working Capital(1.57 B)1.48 B
Note: Payment of 2142 shares by Donald Zakrowski of Eli Lilly subject to Rule 16b-3 [view details]

Eli Lilly Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Eli . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Eli Lilly Buy or Sell Advice

When is the right time to buy or sell Eli Lilly And? Buying financial instruments such as Eli Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2021 2022 2023 2024 (projected)
Short and Long Term Debt Total16.9B16.2B25.2B26.5B
Total Assets48.8B49.5B64.0B67.2B

Use Investing Ideas to Build Portfolios

In addition to having Eli Lilly in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Precious Metals Thematic Idea Now

Precious Metals
Precious Metals Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Precious Metals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Precious Metals Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Eli Lilly And offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Eli Lilly Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Is Eli Lilly's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Eli Lilly. If investors know Eli will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Eli Lilly listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.13
Dividend Share
4.52
Earnings Share
5.84
Revenue Per Share
37.908
Quarterly Revenue Growth
0.281
The market value of Eli Lilly And is measured differently than its book value, which is the value of Eli that is recorded on the company's balance sheet. Investors also form their own opinion of Eli Lilly's value that differs from its market value or its book value, called intrinsic value, which is Eli Lilly's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Eli Lilly's market value can be influenced by many factors that don't directly affect Eli Lilly's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.